SCHEMBL13020165

SCHEMBL13020165

CCn1c(C)c(-c2ccc(Cl)cc2)c2c(NC(=O)C(C)C)ncnc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 4/20 0.39
FGFR1 P11362 1/20 0.38
FGFR4 P22455 1/20 0.38
NOD1 Q9Y239 1/20 0.37
CASP3 P42574 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
MEN1 O00255 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
XIAP P98170 1/20 0.36
BIRC2 Q13490 1/20 0.36
GSK3B P49841 2/20 0.35
KIT P10721 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13020167 0.82 GSK3B (0.49) ALDH1A1KDM4EHTTGSK3BKDR
SCHEMBL13020121 0.79 ADK (0.49) HPGDTSHRNPSR1ALDH1A1KDM4E
SCHEMBL13020205 0.76 CYP1A2 (0.47) TSHRKDM4EHTTKMT2ACDK5
SCHEMBL13020141 0.74 KDR (0.46) HPGDTSHRNPSR1ALDH1A1KDM4E
SCHEMBL13020021 0.72 HTT (0.78) HPGDNPSR1ALDH1A1KDM4EHTT
SCHEMBL13020123 0.72 LCK (0.58) HPGDTSHRNPSR1ALDH1A1KDM4E
SCHEMBL13020113 0.67 ADK (0.47) ALDH1A1KDM4EHTTKDRTEK
SCHEMBL3789169 0.66 KDM4E (0.54) ALDH1A1KDM4EHTTKDRTEK
SCHEMBL13019705 0.66 ALDH1A1 (0.69) NPSR1ALDH1A1KDM4EHTTKMT2A
SCHEMBL13020030 0.65 ADK (0.52) ALDH1A1KDM4EHTTFGFR1FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100331297-A1 MODULATION OF PROTEIN TRAFFICKING FOLDRX PHARMACEUTICALS, INC. (US) 2010-12-30 US disclosed
US-20100331297-A1 MODULATION OF PROTEIN TRAFFICKING FOLDRX PHARMACEUTICALS, INC. (US) 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331297-A1 MODULATION OF PROTEIN TRAFFICKING RAB1A, COPB1, GOLT1B HPGD 4453/4885TSHR 3774/4885NPSR1 2247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.